Loading company…
Riskpilot
← Back to search
Sign in
Get full access
ELIXIR AS
AS
Active
Org 926054740
Lagårdsveien 91, 4010 Stavanger
General medical practice activities · NACE 8621
Est. 2020
1 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 4,2M
+17% vs 2023
EBITDA margin
78.1%
+21% vs 2023
Equity ratio
61.9%
Financial strength
Net profit 2024
NOK 1,4M
-21% vs 2023
EBITDA — year on year
NOK millions
0M
1M
2M
3M
4M
1M
2020
2M
+100%
2021
2M
0%
2022
3M
+50%
2023
3M
0%
2024
Key figures
Annual report 2024
Revenue
NOK 4,2M
+17%
EBITDA
NOK 3,3M
+21%
Net profit
NOK 1,4M
-21%
Total assets
NOK 10,5M
+1%
Equity
NOK 6,5M
+19%
Employees
1
—
Company information
Legal name
ELIXIR AS
Org number
926054740
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
28. november 2020
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Helsetjenester.
Contact
Address
Lagårdsveien 91, 4010 Stavanger
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in General medical practice activities
Companies in Stavanger
All Norway companies
Revenue
NOK millions
0M
1M
2M
3M
5M
2M
2020
3M
2021
3M
2022
4M
2023
4M
2024
EBITDA
NOK millions
0M
1M
2M
3M
3M
1M
2020
2M
2021
2M
2022
3M
2023
3M
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
2 385
2 928
3 080
3 573
4 177
Staff expenses
−0
−0
−0
−388
−492
EBITDA
1 415
2 064
2 111
2 706
3 262
Depreciation & amort.
−0
−158
−160
−202
−171
EBIT
1 415
1 906
1 951
2 505
3 091
Net financials
0
0
230
−288
−1 109
Profit before tax
1 415
1 906
2 181
2 216
1 982
Tax
310
419
417
496
625
Net profit
1 105
1 487
1 764
1 721
1 357
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
1 440
3 135
8 393
10 426
10 479
Equity
1 130
2 616
3 738
5 458
6 486
Long-term debt
0
7
3 218
3 089
2 958
Short-term debt
310
512
1 437
1 878
1 036
Total debt
310
519
4 655
4 968
3 994
Financial ratios
5-year trend
EBITDA margin
78.1%
This company
15.8%
Market median
+394% vs market
2020
2024
Equity ratio
61.9%
This company
38.2%
Market median
+62% vs market
2020
2024
Return on equity
20.9%
This company
18.4%
Market median
+14% vs market
2020
2024
Net profit margin
32.5%
This company
8.1%
Market median
+301% vs market
2020
2024
Asset turnover
0.40×
This company
1.12×
Market median
-64% vs market
2020
2024
Debt / equity
0.62×
This company
0.62×
Market median
+0% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-10-04 – 2020-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Age
Other directorships
CM
Cato Marinius Halvorsen
Chairman
2020
—
—
CK
Cato Knutsen
Chairman
2020
—
—
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
ELIXIR AS
(this company)
K&K Eiendom As
Board network connections
Board members of ELIXIR AS also hold positions in
0
other companies.
Person
Role here
Other companies
Cato Marinius Halvorsen
Chairman
0 companies
Cato Knutsen
Chairman
0 companies